Decoding the Interactions of SM Proteins with SNAREs by Ren-Wang Peng

Get full text

Therapeutic Landscape of Malignant Pleural Mesothelioma: Collateral Vulnerabilities and Evolutionary Dependencies in the Spotlight by Duo Xu, Duo Xu, Haitang Yang, Haitang Yang, Ralph A. Schmid, Ralph A. Schmid, Ren-Wang Peng, Ren-Wang Peng

Get full text

Non-genetic adaptive resistance to KRASG12C inhibition: EMT is not the only culprit by Wenjuan Ning, Wenjuan Ning, Thomas M. Marti, Thomas M. Marti, Patrick Dorn, Patrick Dorn, Ren-Wang Peng, Ren-Wang Peng

Get full text

Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma by Haitang Yang, Duo Xu, Ralph A. Schmid, Ren-Wang Peng

Get full text

Peritumoral CD90+CD73+ cells possess immunosuppressive features in human non-small cell lung cancer by Limei Wang, Haitang Yang, Patrick Dorn, Sabina Berezowska, Fabian Blank, Carlos Wotzkow, Thomas M. Marti, Ren-Wang Peng, Nathalie Harrer, Wolfgang Sommergruber, Gregor J. Kocher, Ralph A. Schmid, Sean R.R. Hall

Get full text

Pharmaco-transcriptomic correlation analysis reveals novel responsive signatures to HDAC inhibitors and identifies Dasatinib as a synergistic interactor in small-cell lung cancer by Haitang Yang, MD-PhD, Beibei Sun, Ke Xu, Yunfei He, Tuo Zhang, Sean R R Hall, Swee T. Tan, Ralph A. Schmid, Ren-Wang Peng, Guohong Hu, Feng Yao, MD-PhD

Get full text

Chemotherapy increases CDA expression and sensitizes malignant pleural mesothelioma cells to capecitabine treatment by Darya Karatkevich, Tereza Losmanova, Philipp Zens, Haibin Deng, Christelle Dubey, Tuo Zhang, Corsin Casty, Yanyun Gao, Christina Neppl, Sabina Berezowska, Wenxiang Wang, Ren-Wang Peng, Ralph Alexander Schmid, Patrick Dorn, Thomas Michael Marti

Get full text

Metabolic synthetic lethality by targeting NOP56 and mTOR in KRAS-mutant lung cancer by Zhang Yang, Shun-Qing Liang, Liang Zhao, Haitang Yang, Thomas M. Marti, Balazs Hegedüs, Yanyun Gao, Bin Zheng, Chun Chen, Wenxiang Wang, Patrick Dorn, Gregor J. Kocher, Ralph A. Schmid, Ren-Wang Peng

Get full text

Chemotherapy-induced CDA expression renders resistant non-small cell lung cancer cells sensitive to 5′-deoxy-5-fluorocytidine (5′-DFCR) by Yanyun Gao, Philipp Zens, Min Su, Camila Anna Gemperli, Haitang Yang, Haibin Deng, Zhang Yang, Duo Xu, Sean R. R. Hall, Sabina Berezowska, Patrick Dorn, Ren-Wang Peng, Ralph Alexander Schmid, Wenxiang Wang, Thomas Michael Marti

Get full text

Synergistic effects of FGFR1 and PLK1 inhibitors target a metabolic liability in KRAS‐mutant cancer by Zhang Yang, Shun‐Qing Liang, Maria Saliakoura, Haitang Yang, Eric Vassella, Georgia Konstantinidou, Mario Tschan, Balazs Hegedüs, Liang Zhao, Yanyun Gao, Duo Xu, Haibin Deng, Thomas M Marti, Gregor J Kocher, Wenxiang Wang, Ralph A Schmid, Ren‐Wang Peng

Get full text

MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma by Haitang Yang, Yanyun Gao, Duo Xu, Ke Xu, Shun-Qing Liang, Zhang Yang, Amina Scherz, Sean R. R. Hall, Stefan Forster, Sabina Berezowska, Feng Yao, Adrian F. Ochsenbein, Thomas M. Marti, Gregor J. Kocher, Ralph A. Schmid, Patrick Dorn, Ren-Wang Peng

Get full text

BAP1 Deficiency Inflames the Tumor Immune Microenvironment and Is a Candidate Biomarker for Immunotherapy Response in Malignant Pleural Mesothelioma by Duo Xu, MD, PhD, Yanyun Gao, PhD, Haitang Yang, MD, PhD, Marc Spils, MD, Thomas M. Marti, PhD, Tereza Losmanová, MD, Min Su, PhD, Wenxiang Wang, MD, Qinghua Zhou, MD, Patrick Dorn, MD, Yongqian Shu, MD, PhD, Ren-Wang Peng, PhD

Get full text

Advancing cancer therapy: new frontiers in targeting DNA damage response by Jiekun Qian, Jiekun Qian, Guoliang Liao, Guoliang Liao, Maohui Chen, Maohui Chen, Ren-Wang Peng, Xin Yan, Jianting Du, Jianting Du, Renjie Huang, Renjie Huang, Maojie Pan, Maojie Pan, Yuxing Lin, Yuxing Lin, Xian Gong, Xian Gong, Guobing Xu, Guobing Xu, Bin Zheng, Bin Zheng, Chun Chen, Chun Chen, Zhang Yang, Zhang Yang

Get full text